Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 438 M417 M463 M446 M477 M 1.8 B Research & development ————— — Operating income 1.54 B927 M1.5 B1.19 B1.6 B 5.22 B Non-Operating Income, Total -458 M-466 M-470 M-463 M-486 M -1.89 B Interest expense, net of interest capitalized 504 M524 M531 M543 M548 M 2.15 B Non-Operating Income, excl. Interest Expenses -510 M-531 M-538 M-548 M-555 M -2.17 B Unusual income/expense 52 M65 M68 M85 M69 M 287 M Pretax income 1.08 B461 M1.03 B722 M1.12 B 3.33 B Equity in earnings ————— — Taxes 170 M70 M155 M128 M200 M 553 M Non-controlling/minority interest ————— — After tax other income/expense -344 M-390 M-354 M-243 M-222 M -1.21 B Net income before discontinued operations 908 M391 M875 M594 M919 M 2.78 B Discontinued operations ————— — Net income 908 M391 M875 M594 M919 M 2.78 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 908 M391 M875 M594 M919 M 2.78 B Basic earnings per share (Basic EPS) 0.90.390.87—0.9 — Diluted earnings per share (Diluted EPS) 0.90.390.860.590.9 2.74 Average basic shares outstanding 1.01 B1.01 B1.01 B1.01 B1.02 B — Diluted shares outstanding 1.01 B1.01 B1.01 B1.01 B1.03 B — EBITDA 2.44 B1.83 B2.42 B2.11 B2.56 B 8.91 B EBIT 1.54 B925 M1.5 B1.18 B1.6 B 5.21 B Cost of revenue 903 M902 M912 M923 M952 M 3.69 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 904 M903 M915 M925 M952 M 3.69 B